{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/UTHR/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T04:44:08.092Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":2331,"canonical_name":"UNITED THERAPEUTICS Corp","cik":"0001082554","uei":null,"lei":null,"duns":null,"ticker":"UTHR"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":208},"count":100,"timeline":[{"ts":"2026-10-13","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-10-13","url_slug":"/sec/cik-0001082554/4/0001106578-26-000161","accession_number":"0001106578-26-000161","importance":30},{"ts":"2026-10-13","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-10-13","url_slug":"/sec/cik-0001082554/4/0001106578-26-000162","accession_number":"0001106578-26-000162","importance":30},{"ts":"2026-10-09","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-10-09","url_slug":"/sec/cik-0001082554/4/0001106578-26-000160","accession_number":"0001106578-26-000160","importance":30},{"ts":"2026-10-08","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-10-08","url_slug":"/sec/cik-0001082554/4/0001106578-26-000159","accession_number":"0001106578-26-000159","importance":30},{"ts":"2026-10-07","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-10-07","url_slug":"/sec/cik-0001082554/4/0001106578-26-000158","accession_number":"0001106578-26-000158","importance":30},{"ts":"2026-10-06","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-10-06","url_slug":"/sec/cik-0001082554/4/0001106578-26-000157","accession_number":"0001106578-26-000157","importance":30},{"ts":"2026-10-05","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-10-05","url_slug":"/sec/cik-0001082554/4/0001106578-26-000156","accession_number":"0001106578-26-000156","importance":30},{"ts":"2026-10-02","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-10-02","url_slug":"/sec/cik-0001082554/4/0001106578-26-000155","accession_number":"0001106578-26-000155","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"144","title":"144 — UNITED THERAPEUTICS Corp — 2026-10-01","url_slug":"/sec/cik-0001082554/144/0001950047-26-009919","accession_number":"0001950047-26-009919","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"144","title":"144 — UNITED THERAPEUTICS Corp — 2026-10-01","url_slug":"/sec/cik-0001082554/144/0001950047-26-009982","accession_number":"0001950047-26-009982","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-10-01","url_slug":"/sec/cik-0001082554/4/0001106578-26-000153","accession_number":"0001106578-26-000153","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-10-01","url_slug":"/sec/cik-0001082554/4/0001106578-26-000154","accession_number":"0001106578-26-000154","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-10-01","url_slug":"/sec/cik-0001082554/4/0001231589-26-000021","accession_number":"0001231589-26-000021","importance":30},{"ts":"2026-09-30","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-09-30","url_slug":"/sec/cik-0001082554/4/0001106578-26-000152","accession_number":"0001106578-26-000152","importance":30},{"ts":"2026-09-29","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-09-29","url_slug":"/sec/cik-0001082554/4/0001106578-26-000151","accession_number":"0001106578-26-000151","importance":30},{"ts":"2026-09-28","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-09-28","url_slug":"/sec/cik-0001082554/4/0001106578-26-000150","accession_number":"0001106578-26-000150","importance":30},{"ts":"2026-09-25","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-09-25","url_slug":"/sec/cik-0001082554/4/0001106578-26-000149","accession_number":"0001106578-26-000149","importance":30},{"ts":"2026-09-24","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-09-24","url_slug":"/sec/cik-0001082554/4/0001106578-26-000148","accession_number":"0001106578-26-000148","importance":30},{"ts":"2026-09-23","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-09-23","url_slug":"/sec/cik-0001082554/4/0001106578-26-000147","accession_number":"0001106578-26-000147","importance":30},{"ts":"2026-09-22","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-09-22","url_slug":"/sec/cik-0001082554/4/0001106578-26-000146","accession_number":"0001106578-26-000146","importance":30},{"ts":"2026-09-21","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-09-21","url_slug":"/sec/cik-0001082554/4/0001106578-26-000145","accession_number":"0001106578-26-000145","importance":30},{"ts":"2026-09-18","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-09-18","url_slug":"/sec/cik-0001082554/4/0001106578-26-000144","accession_number":"0001106578-26-000144","importance":30},{"ts":"2026-09-18","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-09-18","url_slug":"/sec/cik-0001082554/4/0001231589-26-000020","accession_number":"0001231589-26-000020","importance":30},{"ts":"2026-09-17","kind":"sec.filing","form_type":"144","title":"144 — UNITED THERAPEUTICS Corp — 2026-09-17","url_slug":"/sec/cik-0001082554/144/0001950047-26-009611","accession_number":"0001950047-26-009611","importance":30},{"ts":"2026-09-17","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-09-17","url_slug":"/sec/cik-0001082554/4/0001106578-26-000143","accession_number":"0001106578-26-000143","importance":30},{"ts":"2026-09-16","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-09-16","url_slug":"/sec/cik-0001082554/4/0001106578-26-000142","accession_number":"0001106578-26-000142","importance":30},{"ts":"2026-09-15","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-09-15","url_slug":"/sec/cik-0001082554/4/0001106578-26-000141","accession_number":"0001106578-26-000141","importance":30},{"ts":"2026-09-15","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-09-15","url_slug":"/sec/cik-0001082554/4/0001756697-26-000004","accession_number":"0001756697-26-000004","importance":30},{"ts":"2026-09-14","kind":"sec.filing","form_type":"144","title":"144 — UNITED THERAPEUTICS Corp — 2026-09-14","url_slug":"/sec/cik-0001082554/144/0001950047-26-009414","accession_number":"0001950047-26-009414","importance":30},{"ts":"2026-09-14","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-09-14","url_slug":"/sec/cik-0001082554/4/0001106578-26-000140","accession_number":"0001106578-26-000140","importance":30},{"ts":"2026-09-11","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-09-11","url_slug":"/sec/cik-0001082554/4/0001106578-26-000139","accession_number":"0001106578-26-000139","importance":30},{"ts":"2026-09-10","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":2244,"price_per_share":501.8755,"usd_value":1126209,"security_title":"Common Stock","importance":36.126208622},{"ts":"2026-09-10","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":1788,"price_per_share":499.747,"usd_value":893548,"security_title":"Common Stock","importance":35.893547636},{"ts":"2026-09-10","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":1536,"price_per_share":502.7995,"usd_value":772300,"security_title":"Common Stock","importance":35.772300032},{"ts":"2026-09-10","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":1372,"price_per_share":500.5808,"usd_value":686797,"security_title":"Common Stock","importance":35.6867968576},{"ts":"2026-09-10","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":702,"price_per_share":505.0324,"usd_value":354533,"security_title":"Common Stock","importance":35.3545327448},{"ts":"2026-09-10","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":600,"price_per_share":505.9401,"usd_value":303564,"security_title":"Common Stock","importance":35.30356406},{"ts":"2026-09-10","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":578,"price_per_share":503.761,"usd_value":291174,"security_title":"Common Stock","importance":35.291173858},{"ts":"2026-09-10","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":280,"price_per_share":508.8043,"usd_value":142465,"security_title":"Common Stock","importance":35.142465204},{"ts":"2026-09-10","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":280,"price_per_share":506.7621,"usd_value":141893,"security_title":"Common Stock","importance":35.141893388},{"ts":"2026-09-10","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":120,"price_per_share":498.44,"usd_value":59813,"security_title":"Common Stock","importance":35.0598128},{"ts":"2026-09-10","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-09-10","url_slug":"/sec/cik-0001082554/4/0001106578-26-000138","accession_number":"0001106578-26-000138","importance":30},{"ts":"2026-09-10","kind":"sec.insider.m","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":9500,"price_per_share":117.76,"usd_value":1118720,"security_title":"Common Stock","importance":16.11872},{"ts":"2026-09-09","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-09-09","url_slug":"/sec/cik-0001082554/4/0001106578-26-000137","accession_number":"0001106578-26-000137","importance":30},{"ts":"2026-09-08","kind":"sec.filing","form_type":"8-K","title":"8-K — UNITED THERAPEUTICS Corp — 2026-09-08","url_slug":"/sec/cik-0001082554/8-k/0001104659-26-105953","accession_number":"0001104659-26-105953","importance":35},{"ts":"2026-09-08","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-09-08","url_slug":"/sec/cik-0001082554/4/0001106578-26-000136","accession_number":"0001106578-26-000136","importance":30},{"ts":"2026-09-04","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-09-04","url_slug":"/sec/cik-0001082554/4/0001106578-26-000135","accession_number":"0001106578-26-000135","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"144","title":"144 — UNITED THERAPEUTICS Corp — 2026-09-03","url_slug":"/sec/cik-0001082554/144/0001950047-26-009046","accession_number":"0001950047-26-009046","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-09-03","url_slug":"/sec/cik-0001082554/4/0001106578-26-000134","accession_number":"0001106578-26-000134","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-09-03","url_slug":"/sec/cik-0001082554/4/0001231589-26-000019","accession_number":"0001231589-26-000019","importance":30},{"ts":"2026-09-02","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-09-02","url_slug":"/sec/cik-0001082554/4/0001106578-26-000133","accession_number":"0001106578-26-000133","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"144","title":"144 — UNITED THERAPEUTICS Corp — 2026-09-01","url_slug":"/sec/cik-0001082554/144/0001950047-26-008966","accession_number":"0001950047-26-008966","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-09-01","url_slug":"/sec/cik-0001082554/4/0001106578-26-000132","accession_number":"0001106578-26-000132","importance":30},{"ts":"2026-08-31","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-08-31","url_slug":"/sec/cik-0001082554/4/0001106578-26-000131","accession_number":"0001106578-26-000131","importance":30},{"ts":"2026-08-28","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-08-28","url_slug":"/sec/cik-0001082554/4/0001106578-26-000130","accession_number":"0001106578-26-000130","importance":30},{"ts":"2026-08-27","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-08-27","url_slug":"/sec/cik-0001082554/4/0001106578-26-000129","accession_number":"0001106578-26-000129","importance":30},{"ts":"2026-08-26","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-08-26","url_slug":"/sec/cik-0001082554/4/0001106578-26-000128","accession_number":"0001106578-26-000128","importance":30},{"ts":"2026-08-25","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-08-25","url_slug":"/sec/cik-0001082554/4/0001106578-26-000127","accession_number":"0001106578-26-000127","importance":30},{"ts":"2026-08-24","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-08-24","url_slug":"/sec/cik-0001082554/4/0001106578-26-000126","accession_number":"0001106578-26-000126","importance":30},{"ts":"2026-08-21","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-08-21","url_slug":"/sec/cik-0001082554/4/0001106578-26-000125","accession_number":"0001106578-26-000125","importance":30},{"ts":"2026-08-21","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-08-21","url_slug":"/sec/cik-0001082554/4/0001231589-26-000018","accession_number":"0001231589-26-000018","importance":30},{"ts":"2026-08-20","kind":"sec.filing","form_type":"144","title":"144 — UNITED THERAPEUTICS Corp — 2026-08-20","url_slug":"/sec/cik-0001082554/144/0001950047-26-008497","accession_number":"0001950047-26-008497","importance":30},{"ts":"2026-08-20","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-08-20","url_slug":"/sec/cik-0001082554/4/0001106578-26-000124","accession_number":"0001106578-26-000124","importance":30},{"ts":"2026-08-19","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-08-19","url_slug":"/sec/cik-0001082554/4/0001106578-26-000123","accession_number":"0001106578-26-000123","importance":30},{"ts":"2026-08-18","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-08-18","url_slug":"/sec/cik-0001082554/4/0001106578-26-000122","accession_number":"0001106578-26-000122","importance":30},{"ts":"2026-08-17","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-08-17","url_slug":"/sec/cik-0001082554/4/0001106578-26-000121","accession_number":"0001106578-26-000121","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-08-14","url_slug":"/sec/cik-0001082554/4/0001106578-26-000120","accession_number":"0001106578-26-000120","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — UNITED THERAPEUTICS Corp — 2026-08-14","url_slug":"/sec/cik-0001082554/schedule-13g-a/0001104659-26-096403","accession_number":"0001104659-26-096403","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-08-13","url_slug":"/sec/cik-0001082554/4/0001106578-26-000119","accession_number":"0001106578-26-000119","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — UNITED THERAPEUTICS Corp — 2026-08-13","url_slug":"/sec/cik-0001082554/schedule-13g-a/0000902219-26-000284","accession_number":"0000902219-26-000284","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-08-12","url_slug":"/sec/cik-0001082554/4/0001106578-26-000118","accession_number":"0001106578-26-000118","importance":30},{"ts":"2026-08-11","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-08-11","url_slug":"/sec/cik-0001082554/4/0001106578-26-000117","accession_number":"0001106578-26-000117","importance":30},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":3027,"price_per_share":530.2613,"usd_value":1605101,"security_title":"Common Stock","importance":36.6051009551},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":1050,"price_per_share":529.2671,"usd_value":555730,"security_title":"Common Stock","importance":35.555730455},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":731,"price_per_share":528.3963,"usd_value":386258,"security_title":"Common Stock","importance":35.3862576953},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":722,"price_per_share":527.3809,"usd_value":380769,"security_title":"Common Stock","importance":35.3807690098},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":640,"price_per_share":531.1493,"usd_value":339936,"security_title":"Common Stock","importance":35.339935552},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":582,"price_per_share":524.858,"usd_value":305467,"security_title":"Common Stock","importance":35.305467356},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":578,"price_per_share":523.9474,"usd_value":302842,"security_title":"Common Stock","importance":35.3028415972},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":514,"price_per_share":536.2326,"usd_value":275624,"security_title":"Common Stock","importance":35.2756235564},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":459,"price_per_share":532.2803,"usd_value":244317,"security_title":"Common Stock","importance":35.2443166577},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":391,"price_per_share":533.2113,"usd_value":208486,"security_title":"Common Stock","importance":35.2084856183},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":286,"price_per_share":535.2742,"usd_value":153088,"security_title":"Common Stock","importance":35.1530884212},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":214,"price_per_share":538.8628,"usd_value":115317,"security_title":"Common Stock","importance":35.1153166392},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":186,"price_per_share":537.9138,"usd_value":100052,"security_title":"Common Stock","importance":35.1000519668},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":120,"price_per_share":525.7299,"usd_value":63088,"security_title":"Common Stock","importance":35.063087588},{"ts":"2026-08-10","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-08-10","url_slug":"/sec/cik-0001082554/4/0001106578-26-000116","accession_number":"0001106578-26-000116","importance":30},{"ts":"2026-08-10","kind":"sec.insider.m","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":9500,"price_per_share":135.42,"usd_value":1286490,"security_title":"Common Stock","importance":16.28649},{"ts":"2026-08-07","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-08-07","url_slug":"/sec/cik-0001082554/4/0001106578-26-000115","accession_number":"0001106578-26-000115","importance":30},{"ts":"2026-08-06","kind":"sec.filing","form_type":"144","title":"144 — UNITED THERAPEUTICS Corp — 2026-08-06","url_slug":"/sec/cik-0001082554/144/0001950047-26-007724","accession_number":"0001950047-26-007724","importance":30},{"ts":"2026-08-06","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-08-06","url_slug":"/sec/cik-0001082554/4/0001106578-26-000114","accession_number":"0001106578-26-000114","importance":30},{"ts":"2026-08-06","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-08-06","url_slug":"/sec/cik-0001082554/4/0001231589-26-000017","accession_number":"0001231589-26-000017","importance":30},{"ts":"2026-08-05","kind":"sec.filing","form_type":"10-Q","title":"10-Q — UNITED THERAPEUTICS Corp — 2026-08-05","url_slug":"/sec/cik-0001082554/10-q/0001082554-26-000027","accession_number":"0001082554-26-000027","importance":45},{"ts":"2026-08-05","kind":"sec.filing","form_type":"8-K","title":"8-K — UNITED THERAPEUTICS Corp — 2026-08-05","url_slug":"/sec/cik-0001082554/8-k/0001082554-26-000028","accession_number":"0001082554-26-000028","importance":35},{"ts":"2026-08-05","kind":"sec.filing","form_type":"4","title":"4 — UNITED THERAPEUTICS Corp — 2026-08-05","url_slug":"/sec/cik-0001082554/4/0001106578-26-000113","accession_number":"0001106578-26-000113","importance":30},{"ts":"2026-08-04","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":3142,"price_per_share":517.496,"usd_value":1625972,"security_title":"Common Stock","importance":36.625972432},{"ts":"2026-08-04","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":2456,"price_per_share":516.5935,"usd_value":1268754,"security_title":"Common Stock","importance":36.268753636},{"ts":"2026-08-04","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":1446,"price_per_share":518.3964,"usd_value":749601,"security_title":"Common Stock","importance":35.7496011944},{"ts":"2026-08-04","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":675,"price_per_share":514.4272,"usd_value":347238,"security_title":"Common Stock","importance":35.34723836},{"ts":"2026-08-04","kind":"sec.insider.s","reporter":"ROTHBLATT MARTINE A","title":"Chairperson & CEO","shares":605,"price_per_share":515.4991,"usd_value":311877,"security_title":"Common Stock","importance":35.3118769555}]}